diet physical*sustained weight loss*weight weekly*medical monitoring*weight maintenance program*medical care setting*diet choice*comprehensive weight maintenance*total meal replacement*baseline body weight*lifestyle intervention*maintenance counseling*weight maintenance counseling*loss such program*comprehensive weight*meal replacement*comprehensive weight loss*lifestyle program*weight maintenance*monthly contact*weight loss maintenance*energy deficit*loss sustained weight*term weight loss*necessary energy*diet physical activity*intensive behavioral lifestyle*loss maintenance program*term weight*behavioral lifestyle*body weight weekly*necessary energy deficit*sustained weight*least monthly contact*total meal*trained practitioner*loss maintenance*obese patient*baseline body*trained interventionists*behavioral strategy*close medical monitoring*behavioral lifestyle intervention*trained interventionist*calorie diet*weight loss goal*short term weight
lifestyle support*obese patient*modeling study*longer study*weight loss treatment*pharmacological therapy*weight management program*lifelong lifestyle*medical monitoring*severe obesity*retrospective analysis*comprehensive weight management*metabolic surgery*gastric banding*effective weight loss*nonsurgical subject*lifelong lifestyle support*optimal medical therapy*comprehensive weight*metabolic profile
aglucosidase*diet physical*insufficient weight loss*lowering medication*diabetes provider*weight loss medication*behavioral counseling*glucose lowering medication*glucose lowering*alternative medication*possible medication*tolerability issue*loss medication*concomitant medication*diet physical activity*aglucosidase inhibitor*insufficient weight*obese patient*successful weight loss*pharmacological treatment*alpha glucosidase
activity goal*rate gfr*glycemic goal*glomerular filtration rate*longstanding evidence base*min week*physical activity goal*goal metformin monotherapy*ml min*lower gfr range*counseling setting*filtration rate gfr*week minimum*goal metformin*metformin monotherapy*longstanding evidence*min week minimum*lower gfr*lifestyle effort*glycemic goal metformin*gfr range
loss ketosis*ongoing glycemia reduction*inhibitor glp1 analog*glycemic effect*inhibitor glp1*sulfonylurea dpp4*dpp4*dpp4 inhibitor glp1*comparative effectiveness study*moderate glycemic effect*dipeptidyl peptidase*glucose toxicity*catabolic feature weight*postprandial hypoglycemia*study grade*reduction approach*glycemia*glp1 analog*dpp4 inhibitor*postprandial*dpp iv*secretagogues meglitinides*newer agent*feature weight loss*sulfonylurea*secretagogues*late postprandial hypoglycemia*class sulfonylurea dpp4*effectiveness study grade*health economic outcome*weight loss ketosis*irregular meal*basal insulin*ongoing glycemia*class sulfonylurea*glp 1*feature weight*moderate glycemic*catabolic feature*glucagon like peptide*effectiveness study*meglitinides*glycemia reduction*irregular meal schedule*medical psychosocial*meal schedule*drug class*glp1*drug class sulfonylurea*glycemia reduction approach*major drug class*combination regimen*dpp 4*sulfonylurea dpp4 inhibitor
insulin administration*noninsulin agent*insulin analog*inhibitor glp1*sulfonylurea dpp4*acceptable fasting*concentrated preparation*insulin dosing*dpp4*glycemic goal*dpp4 inhibitor glp1*dosing range*dipeptidyl peptidase*glp1 receptor*bolus insulin*glycemic goal provider*initiate insulin therapy*limited dosing range*injectable therapy*csii*pharmacodynamic profile*dpp4 inhibitor*initiate insulin*postprandial*glp1 receptor agonist*combination injectable therapy*noninsulin*dpp iv*u200*insulin dos*sulfonylurea*progressive nature*insulin regimen*accurate dosing*serial lung function*insulin analog people*complex insulin regimen*postprandial glucose excursion*part mix*u300 glargine*blood glucose level*basal insulin*suboptimal blood glucose*degludec*blood glucose control*glp 1*postprandial glucose*acceptable fasting blood*insulin therapy*suboptimal blood*prandial*glucagon like peptide*u300*receptor agonist*regimen flexibility*complex insulin*thiazolidinediones*dos adjunctive use*glucose excursion*adjunctive use*analog people*sglt2 inhibitor*limited dosing*prandial use*glp1*basal insulin analog*bolus insulin dosing*serial lung*u200 degludec*lispro*goal provider*lung function testing*dpp 4*sulfonylurea dpp4 inhibitor*smaller volume
min week
